Gilteritinib For Patients With FLT3+ AML
Edward Copelan, MD Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute Discusses Gilteritinib For Patients With FLT3+ AML At The 60th ASH Annual Meeting on Dec 1, 20...
Author: obr
Added: 01/11/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts